127 related articles for article (PubMed ID: 38664256)
21. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
[TBL] [Abstract][Full Text] [Related]
22. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
23. Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival.
Meterissian SH; Skibber JM; Giacco GG; el-Naggar AK; Hess KR; Rich TA
Surgery; 1997 May; 121(5):479-87. PubMed ID: 9142144
[TBL] [Abstract][Full Text] [Related]
24. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
25. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
26. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
27. Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma.
Luna-Perez P; Delgado S; Labastida S; Ortiz N; Rodriguez D; Herrera L
Ann Surg Oncol; 1996 Nov; 3(6):526-33. PubMed ID: 8915483
[TBL] [Abstract][Full Text] [Related]
28. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.
PelvEx Collaborative
Colorectal Dis; 2020 Oct; 22(10):1258-1262. PubMed ID: 32294308
[TBL] [Abstract][Full Text] [Related]
30. Comparison of immediate surgical outcomes between posterior pelvic exenteration and standard resection for primary rectal cancer: a matched case-control study.
Lohsiriwat V; Lohsiriwat D
World J Gastroenterol; 2008 Apr; 14(15):2414-7. PubMed ID: 18416472
[TBL] [Abstract][Full Text] [Related]
31. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
[TBL] [Abstract][Full Text] [Related]
32. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
33. [Surgical outcomes for 187 patients with locally recurrent rectal cancer and analysis of prognostic factors].
Jiang Y; Wan YL; Liu YC; Wang X; Pan YS; Wu T; Wang PY; Huang SJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):582-5. PubMed ID: 21866446
[TBL] [Abstract][Full Text] [Related]
34. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
[No Abstract] [Full Text] [Related]
37. Laparoscopic Posterior Pelvic Exenteration (Complete and Supralevator) for Locally Advanced Adenocarcinoma of the Rectum in Females: Surgical Technique and Short-Term Outcomes.
Pokharkar A; Bankar S; Rohila J; Jaiswal D; deSouza A; Saklani A
J Laparoendosc Adv Surg Tech A; 2020 May; 30(5):558-563. PubMed ID: 31794331
[No Abstract] [Full Text] [Related]
38. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
39. Quality of life of survivors after pelvic exenteration for rectal cancer.
Austin KK; Young JM; Solomon MJ
Dis Colon Rectum; 2010 Aug; 53(8):1121-6. PubMed ID: 20628274
[TBL] [Abstract][Full Text] [Related]
40. Modified posterior pelvic exenteration for advanced ovarian malignancies: a single-institution study of 35 cases.
Minar L; Felsinger M; Rovny I; Zlamal F; Bienertova-Vasku J; Jandakova E
Acta Obstet Gynecol Scand; 2017 Sep; 96(9):1136-1143. PubMed ID: 28585317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
